Ketotifen, a new prophylactic agent in asthma
Giesen, H.K.; Fryda-Kaurimsky, Z.
Medizinische Klinik 74(42): 1553-1556
1979
ISSN/ISBN: 0025-8458 PMID: 231737 Document Number: 147981
12 patients with bronchial asthma received treatment with Ketotifen for three months. 8 patients then continued this medication for at least 9 months. During this period it was possible to reduce the amount of theophylline and bronchodilator amines as well as the maintenance dose of corticosteroids. Afterwards 6 patients showed clinical deterioration while on placebo; this was considered further evidence of the anti-asthmatic effect of Ketotifen. Ketotifen seems to be acceptable as a prophylactic agent in asthma.